Is Duodenal Invasion a Relevant Prognosticator in Patients Undergoing Adjuvant Chemoradiotherapy for Distal Common Bile Duct Cancer?

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 4, 2010, Pages 1186-1190

  Kim, Kyubo ^a   Chie, Eui Kyu ^a   Jang, Jin Young ^a   Kim, Sun Whe ^a   Oh, Do Youn ^a   Im, Seock Ah ^a   Kim, Tae You ^a   Bang, Yung Jue ^a   Ha, Sung W ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Adjuvant chemoradiotherapy; Distal common bile duct cancer; Duodenal invasion

Indexed keywords

5-FLUOROURACIL; ADJUVANT RADIOTHERAPY; CHEMORADIOTHERAPY; COMMON BILE DUCTS; HISTOLOGIC DIFFERENTIATION; LYMPH NODE; MULTI VARIATE ANALYSIS; OVERALL SURVIVAL; OVERALL SURVIVAL RATES; PROGNOSTIC FACTORS; RISK FACTORS; SIGNIFICANT IMPACTS; TREATMENT OUTCOMES; TUMOR BED; TUMOR SIZE; TUMOR STAGING; UNIVARIATE ANALYSIS; UP PERIOD;

BODY FLUIDS; DECISION MAKING; DUCTS; MULTIVARIANT ANALYSIS; SURGERY;

TUMORS;

DOXORUBICIN; FLUOROURACIL; MITOMYCIN; MITOMYCIN C; TEGAFUR; URACIL;

ABDOMINAL PAIN; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BILE DUCT CANCER; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; DIARRHEA; DUODENUM; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MALE; NAUSEA; OVERALL SURVIVAL; PANCREAS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RISK FACTOR; TREATMENT OUTCOME; TUMOR VOLUME; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COMMON BILE DUCT NEOPLASMS; DUODENAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SURVIVAL RATE; TUMOR BURDEN;

EID: 77953575863     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.06.033     Document Type: Article

References (19)

1. Yeo C.J., Sohn T.A., Cameron J.L., et al. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227 (1998) 821-831
2. de Castro S.M.M., Kuhlmann K.F.D., van Heek N.T., et al. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy. J Gastrointest Surg 8 (2004) 775-784
3. Nakeeb A., Pitt H.A., Sohn T., et al. Cholangiocarcinoma: A spectrum of intrahepatic, perihilar and distal tumors. Ann Surg 224 (1996) 463-473
4. Fong Y., Blumgart L.H., Lin E., et al. Outcome of treatment for distal bile duct cancer. Br J Surg 83 (1996) 1712-1715
5. Zerbi A., Balzano G., Leone B.E., et al. Clinical presentation, diagnosis and survival of resected distal bile duct cancer. Dig Surg 15 (1998) 410-416
6. Yoshida T., Matsumoto T., Sasaki A., et al. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Arch Surg 137 (2002) 69-73
7. Serafini F.M., Sachs D., Bloomston M., et al. Location, not staging, of cholangiocarcinoma determines the role of adjuvant chemoradiation therapy. Am Surgeon 67 (2001) 839-844
8. Hughes M.A., Frassica D.A., Yeo C.J., et al. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys 68 (2007) 178-182
9. Heron D.E., Stein D.E., Eschelman D.J., et al. Cholangiocarcinoma: The impact of tumor location and treatment strategy on outcome. Am J Clin Oncol 26 (2003) 422-428
10. Hejna M., Pruckmayer M., and Raderer M. The role of chemotherapy and radiation on the management of biliary cancer: A review of the literature. Eur J Cancer 34 (1998) 977-986
11. Kaplan E.L., and Meier P.I. A nonparametric estimation from incomplete observations. J Am Statics Assoc 53 (1958) 457-481
12. American Joint Committee on Cancer (AJCC). AJCC Cancer staging handbook. 6th ed. (2002), Springer-Verlag, New York p. 107-112
13. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
14. Miller A.B., Hoogstraten B., Staquet M., et al. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
15. Kamada T., Saitou H., Takamura A., et al. The role of radiotherapy in the management of extrahepatic bile duct cancer: An analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys 34 (1996) 767-774
16. Kim S., Kim S.W., Bang Y.J., et al. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 54 (2002) 414-419
17. Nelson J.W., Ghafoori A.P., Willett C.G., et al. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 73 (2009) 148-153
18. Ben-David M.A., Griffith K.A., Abu-Isa E., et al. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 66 (2006) 772-779
19. Ebata T., Nagino M., Nishio H., et al. Pancreatic and duodenal invasion in distal bile duct cancer: Paradox in the tumor classification of the American Joint Committee on Cancer. World J Surg 31 (2007) 2008-2015